Request Deal Involvement

Charles River Laboratories completed the acquisition of Cognate BioServices for $875m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Morgan Stanley

financial advisors

Morgan Stanley

Kirkland & Ellis

legal advisors

Kirkland & Ellis

Davis Polk & Wardwell

legal advisors

Davis Polk & Wardwell

Gordon Dyal & Co

financial advisors

Gordon Dyal & Co

Weil Gotshal and Manges

legal advisors

Weil Gotshal and Manges

Dark Horse Consulting Group

commercial advisors

Dark Horse Consulting Group

Simpson Thacher & Bartlett

legal advisors to financial advisors

Simpson Thacher & Bartlett

Sard Verbinnen & Co

pr advisors

Sard Verbinnen & Co

Hannes Snellman (Pre-reorganization)

legal advisors

Hannes Snellman (Pre-reorganization)

or

Principals

COGNATE BIOSERVICES

target

COGNATE BIOSERVICES

CHARLES RIVER LABORATORIES INTERNATIONAL INC

bidder

CHARLES RIVER LABORATORIES INTERNATIONAL INC

EW HEALTHCARE PARTNERS

vendor

EW HEALTHCARE PARTNERS

MEDIVATE PARTNERS

vendor

MEDIVATE PARTNERS

BLACKROCK

vendor

BLACKROCK

TENNENBAUM CAPITAL PARTNERS

vendor

TENNENBAUM CAPITAL PARTNERS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Charles River Laboratories completed the acquisition of Cognate BioServices for $875m.